Free to read · nothing for sale · no ads, no sponsors · funded by donation

Open Source Apothecary At Home

Open Source Apothecary At Home / Metabolic and endocrine

Type 2 diabetes: the herbs with glycaemic trials, and the one that is nearly a drug

Berberine, cinnamon and fenugreek all lower blood sugar modestly. Berberine does it as a drug.

remedy

Several plant preparations lower blood glucose modestly. The effect sizes are usually small — a reduction in fasting glucose and HbA1c of less than a typical drug's worth — and the trials are commonly small and of short duration. The framing that matters: these are adjuncts to a treatment plan, and diabetes is a disease where the complications are prevented by glycaemic control, blood pressure control, lipid control and screening for eye, kidney and foot disease. A herb that reduces HbA1c by 0.3% does not replace any of that.

Berberine has the strongest evidence of the group, with multiple small trials showing reductions in fasting glucose, postprandial glucose and HbA1c comparable in some trials to metformin. It works partly by activating AMPK. Two important cautions: it is a potent CYP3A4 and P-glycoprotein inhibitor, which raises the levels of many co-administered drugs, and it is not for use in pregnancy or breastfeeding (it is used traditionally as an abortifacient and it can displace bilirubin in newborns).

Cinnamon — pooled analyses show a small reduction in fasting glucose, with notable heterogeneity and a pattern where the larger and better-designed trials find less effect. Cassia cinnamon, the cheap common type, contains coumarin, which is hepatotoxic at high doses; Ceylon cinnamon does not. Anyone taking cinnamon daily for months should use Ceylon.

Fenugreek — seeds have small trials showing glycaemic benefit. It also has an obvious culinary use. It can cause GI upset and it smells strongly of maple.

Alpha-lipoic acid — trials in diabetic neuropathy (see that page) and some evidence for glycaemic effects.

Chromium, gymnema, bitter melon — small trials, inconsistent results, and bitter melon in particular can cause hypoglycaemia when combined with glucose-lowering drugs.

Magnesium and vitamin D — both have been associated with glycaemic measures, and correcting a deficiency is reasonable. Supplementing beyond sufficiency has not shown consistent benefit.

Inositol — has trials in polycystic ovary syndrome, where it improves insulin sensitivity and ovulation.

The intervention with the best evidence of anything on this page: weight loss (substantial weight loss can put type 2 diabetes into remission), diet quality, exercise, and taking the prescribed medicines. Hypoglycaemia is the main risk of adding any of these to a sulfonylurea or insulin — monitor more, not less, when adding a supplement.

What the studies found

Meta-Analysis2026PloS one

Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study.

Probiotics, synbiotics, and BBR provide statistically significant but clinically modest improvements in glycemic control.
PubMed 42213651 ↗
Meta-Analysis2025Nutrition reviews

Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis.

The data suggest that cinnamon improves the glycemic and lipid profile and reduces the BMI, particularly in DM2 patients who receive cinnamon supplementation in capsule form and at a dose of ≤2 g/day.
PubMed 38917435 ↗
Meta-Analysis2025BMJ open

Alpha-lipoic acid on intermediate disease markers in overweight or obese adults: a systematic review and meta-analysis.

No significant associations were detected between ALA intake and intermediate disease markers, including TG, TC, HDL-C, LDL-C, HOMA-IR and FBS levels, in overweight or obese adults.
PubMed 40180416 ↗
Meta-Analysis2025Sultan Qaboos University medical journal

Effect of Magnesium Supplements on Improving Glucose Control, Blood Pressure and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A systematic review and meta-analysis.

This review highlights the importance of considering patient characteristics, dosage and intervention duration in future research on Mg supplementation for glycaemic control in diabetes.
PubMed 40641714 ↗
Meta-Analysis2025Nature communications

Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial.

Observational and experimental evidence suggests that vitamin D plays a role in type 2 diabetes (T2D).
PubMed 40199888 ↗
Meta-Analysis2025Endocrine

Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.

In this meta-analysis of RCTs, combination therapy was associated with cycle regularization and reduction in hirsutism and LH/FSH ratio compared to metformin monotherapy.
PubMed 39331347 ↗

Preparation

Berberine

  • 500 mg two to three times daily before meals, as used in the trials
  • Potent CYP3A4 and P-gp inhibitor — check every medicine
  • Not in pregnancy or breastfeeding. Not in infants (bilirubin displacement).
  • GI upset is common at first; take with food

Cinnamon

  • 1/2 to 1 teaspoon (1-3 g) daily, in food or as capsules
  • Use Ceylon cinnamon for daily long-term use. Cassia contains coumarin, which is hepatotoxic.
  • The effect is small

Fenugreek

  • 1-2 teaspoons of ground seed daily, soaked in water or in food
  • Soaking reduces the bitterness and the GI effect
  • Smells strongly of maple; harmless

Alpha-lipoic acid

  • 600 mg daily in the neuropathy trials
  • May add to glucose-lowering drugs

Magnesium and vitamin D

  • Correct a documented deficiency; do not megadose
  • Magnesium is dangerous in kidney impairment, which is common in diabetes — check kidney function first

Inositol (PCOS)

  • 2 g of myo-inositol twice daily is a common trial dose
  • Discuss with an endocrinologist or gynaecologist

Monitoring — this is the safety net

  • Monitor blood glucose more often when adding anything, especially if on insulin or a sulfonylurea
  • An HbA1c every 3-6 months
  • Annual eye screening, kidney function and urine albumin, and foot examination. These prevent the complications, and no herb substitutes for them.

The intervention with the best evidence

  • Weight loss: substantial weight loss achieved with diet, and in some cases with medication or surgery, can achieve diabetes remission
  • Exercise: resistance training and aerobic exercise both improve glycaemic control
  • Diet quality: reduce refined carbohydrate and sugar-sweetened drinks; increase fibre, vegetables, legumes

Cautions and interactions

When this is not a self-care problem — get help

Known interactions

Related

Sources

  1. Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study. PloS one 2026; doi:10.3390/biom14010099 PubMed 42213651
  2. Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis. Nutrition reviews 2025; doi:10.1093/nutrit/nuae058 PubMed 38917435
  3. Alpha-lipoic acid on intermediate disease markers in overweight or obese adults: a systematic review and meta-analysis. BMJ open 2025; doi:10.1016/j.bbagen.2009.07.026 PubMed 40180416
  4. Effect of Magnesium Supplements on Improving Glucose Control, Blood Pressure and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A systematic review and meta-analysis. Sultan Qaboos University medical journal 2025; doi:10.1080/07315724.2004.10719389 PubMed 40641714
  5. Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial. Nature communications 2025; doi:10.1007/BF00280883 PubMed 40199888
  6. Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Endocrine 2025; doi:10.1007/s40618-021-01691-5 PubMed 39331347